申请人:Muller W. George
公开号:US20050090516A1
公开(公告)日:2005-04-28
Novel imides are inhibitors of tumor necrosis factor alpha and can be used to combat cachexia, endotoxic shock, and retrovirus replication. A typical embodiment is (R)-2-Phthalimido-3-(3′,4′-dimethoxyphenyl)propane.
新型咪唑衍生物是肿瘤坏死因子α的抑制剂,可用于对抗消瘦症、内毒素休克和逆转录病毒复制。典型的实施例是(R)-2-邻苯二甲酰亚胺基-3-(3′,4′-二甲氧基苯基)丙烷。